Erenumab

Tax included
Erenumab is a fully human monoclonal antibody. Erenumab inhibits the calcitonin gene–related peptide (CGRP) receptor. Erenumab can be used for the prevention of episodic migraine.
MedChemExpress 
HY-P9938

Data sheet

Size
Multiple sizes
Reactivity
CGRP Receptor
Application
Neuroscience-Neuromodulation
CAS
1582205-90-0